bluebird bio, Inc. (BLUE) Stock Price, News, Quote & History
Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing.
bluebird bio, Inc. (BLUE) Interactive Stock Chart - Yahoo Finance
Interactive Chart for bluebird bio, Inc. (BLUE), analyze all the data with a huge range of indicators.
bluebird bio, Inc. (BLUE) Latest Stock News & Headlines - Yahoo …
Get the latest bluebird bio, Inc. (BLUE) stock news and headlines to help you in your trading and investing decisions.
bluebird bio, Inc. (BLUE) Stock Historical Prices & Data - Yahoo …
Discover historical prices for BLUE stock on Yahoo Finance. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued.
bluebird bio Reports Second Quarter 2024 Results and Highlights ...
SOMERVILLE, Mass., August 14, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported second quarter results and business highlights for the quarter ended June 30 ...
bluebird bio, Inc. (BLUE) Options Chain - Yahoo Finance
ALLO Allogene Therapeutics, Inc. 3.0800. -3.45%. View the basic BLUE option chain and compare options of bluebird bio, Inc. on Yahoo Finance.
bluebird bio (BLUE): Promising Gene Editing Stock with FDA …
In this article, we are going to take a look at where bluebird bio, Inc. (NASDAQ:BLUE) stands against other most promising gene editing stocks to buy according to hedge funds.
bluebird bio Announces FDA Approval of LYFGENIA™ …
Dec 8, 2023 · bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events.
bluebird bio, Inc. (BLUE) - Yahoo Finance
See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
bluebird bio, Inc. (BLUE) Stock Forum & Discussion - Yahoo Finance
Find the latest bluebird bio, Inc. (BLUE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.